Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

McKinsey
Dow
Moodys
Baxter
McKesson
Harvard Business School

Last Updated: October 17, 2019

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR BALSALAZIDE DISODIUM

See Plans and Pricing

« Back to Dashboard

Clinical Trials for Balsalazide Disodium

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00269438 New Tablet Formulation and Dosing Regimen of Balsalazide Disodium in Mildly to Moderately Active Ulcerative Colitis Completed Valeant Pharmaceuticals International, Inc. Phase 3 2005-12-01 The purpose of this study is to establish the efficacy and safety of a new tablet formulation and dosing regimen of balsalazide disodium dosed twice daily in achieving clinical improvement in subjects with mildly to moderately active ulcerative colitis after 8 weeks of therapy.
NCT00408174 Balsalazide Disodium vs. Mesalamine in Mildly to Moderately Active Ulcerative Colitis Completed Valeant Pharmaceuticals International, Inc. Phase 3 2006-05-01 To establish the efficacy and safety of a new tablet formulation and dosing regimen of balsalazide disodium dosed twice daily in achieving clinical improvement in subjects with mildly to moderately active ulcerative colitis after 6 weeks of therapy.
NCT00486031 Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study Completed Valeant Pharmaceuticals International, Inc. Phase 3 2006-10-01 The objective of the study is to evaluate the long-term safety and tolerability of treatment with balsalazide disodium tablets in subjects who are in remission from ulcerative colitis or who have mildly to moderately active UC.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Balsalazide Disodium

Condition Name

Condition Name for Balsalazide Disodium
Intervention Trials
Ulcerative Colitis 5
Inflammatory Bowel Disease 2
Healthy 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Balsalazide Disodium
Intervention Trials
Colitis, Ulcerative 5
Colitis 3
Ulcer 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Balsalazide Disodium

Trials by Country

Trials by Country for Balsalazide Disodium
Location Trials
United States 90
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Balsalazide Disodium
Location Trials
Texas 5
Ohio 3
Louisiana 3
Iowa 3
Michigan 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Balsalazide Disodium

Clinical Trial Phase

Clinical Trial Phase for Balsalazide Disodium
Clinical Trial Phase Trials
Phase 3 3
Phase 1 2
N/A 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Balsalazide Disodium
Clinical Trial Phase Trials
Completed 7
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Balsalazide Disodium

Sponsor Name

Sponsor Name for Balsalazide Disodium
Sponsor Trials
Valeant Pharmaceuticals International, Inc. 3
Roxane Laboratories 2
Mylan Pharmaceuticals 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Balsalazide Disodium
Sponsor Trials
Industry 7
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
McKesson
Express Scripts
McKinsey
Johnson and Johnson
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.